Cellpro Biotechnology Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
500
- Latest Deal Type
-
2ndary - Private
- Investors
-
12
Cellpro Biotechnology General Information
Description
Developers and producers of biomedical plasticware intended for molecular diagnosis, cell culture and immunotherapy. The company focuses on providing global customers with consumables and customized services in the fields of molecular diagnosis, cell culture and immunotherapy, enabling clients to obtain high-quality and customized biological consumables.
Contact Information
Website
www.cellprobio.comCorporate Office
- Building 1, No. 18, Dongchang Road
- Suzhou Industrial Park
- Suzhou, Jiangsu
- China
Corporate Office
- Building 1, No. 18, Dongchang Road
- Suzhou Industrial Park
- Suzhou, Jiangsu
- China
Cellpro Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | Completed | |||||
| 5. Early Stage VC (Series B) | 16-Sep-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 29-Dec-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 08-Aug-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 24-Feb-2020 | Completed | Generating Revenue | |||
| 1. Corporate | 20-Jan-2019 | Completed | Startup |
Cellpro Biotechnology Patents
Cellpro Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025044031-A1 | Closed cell culture device with high gas permeability and method | Inactive | 29-Aug-2023 | ||
| US-20250075161-A1 | Highly-breathable closed cell culture device and method | Inactive | 29-Aug-2023 |
Cellpro Biotechnology Signals
Cellpro Biotechnology Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China-Singapore Suzhou Industrial Park Development Group | Corporation | Minority | ||
| CICC Capital | PE/Buyout | Minority | ||
| Xiamen Venture Capital | Corporate Venture Capital | Minority | ||
| YuanBio Venture Capital | Venture Capital | Minority | ||
| Caleb Capital | Growth/Expansion | Minority |
Cellpro Biotechnology FAQs
-
When was Cellpro Biotechnology founded?
Cellpro Biotechnology was founded in 2018.
-
Where is Cellpro Biotechnology headquartered?
Cellpro Biotechnology is headquartered in Suzhou, China.
-
What is the size of Cellpro Biotechnology?
Cellpro Biotechnology has 500 total employees.
-
What industry is Cellpro Biotechnology in?
Cellpro Biotechnology’s primary industry is Other Devices and Supplies.
-
Is Cellpro Biotechnology a private or public company?
Cellpro Biotechnology is a Private company.
-
What is Cellpro Biotechnology’s current revenue?
The current revenue for Cellpro Biotechnology is .
-
Who are Cellpro Biotechnology’s investors?
China-Singapore Suzhou Industrial Park Development Group, CICC Capital, Xiamen Venture Capital, YuanBio Venture Capital, and Caleb Capital are 5 of 12 investors who have invested in Cellpro Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process